Date published: 2026-1-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

eHAND Inhibitors

eHAND inhibitors are a class of chemical compounds that function by selectively inhibiting the activity of the eHAND (extra-helical Nuclear Antigenic Determinant) protein, a transcription factor crucial for gene expression regulation. eHAND, also known as HAND1 (Heart and Neural Crest Derivatives Expressed 1), is a basic helix-loop-helix (bHLH) transcription factor that plays a significant role in the regulation of various cellular processes, including cellular differentiation, proliferation, and apoptosis. The inhibition of eHAND disrupts its ability to bind to specific DNA sequences, thereby preventing the transcription of target genes involved in these critical biological functions. The design and development of eHAND inhibitors require a deep understanding of the structural biology of eHAND, particularly its DNA-binding domain, which is essential for its interaction with target genes. The structure-activity relationship (SAR) of eHAND inhibitors is a vital aspect of their study, as it provides insights into how modifications to the chemical structure of these inhibitors can enhance or reduce their efficacy. This class of inhibitors often exhibits a high degree of specificity due to the unique structural motifs present in the eHAND protein. The bHLH domain, for instance, is a key target for these inhibitors, as it is directly involved in dimerization and DNA binding, which are critical for eHAND's function. Advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are often employed to elucidate the precise binding interactions between eHAND and its inhibitors, enabling the rational design of more potent and selective compounds. Furthermore, understanding the metabolic stability and bioavailability of eHAND inhibitors is crucial for determining their effectiveness in various experimental models. Overall, eHAND inhibitors represent a highly specialized and intricate class of compounds with significant implications for the study of gene regulation and cellular function.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GSK-3 Inhibitor XVI

252917-06-9sc-221691
sc-221691A
5 mg
25 mg
$180.00
$610.00
4
(1)

Inhibits GSK3β, which can modulate Wnt signaling, indirectly affecting transcription factors including eHAND.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Inhibits PKC, which can alter cardiac transcription factor pathways, indirectly influencing eHAND activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibits MEK, which is upstream in MAPK/ERK signaling, potentially altering eHAND′s transcriptional activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Inhibits HDAC, affecting chromatin structure and gene expression, possibly affecting eHAND's regulatory functions.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, affecting AKT signaling and potentially influencing transcription factors like eHAND.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Inhibits JAK, which may affect STAT signaling, potentially altering eHAND's function.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Blocks calcium channels, potentially affecting calcium-dependent signaling pathways and eHAND activity.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Inhibits L-type calcium channels, which may indirectly affect eHAND's activity in cardiac cells.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

Inhibitor of gamma-secretase, modulating Notch signaling, potentially influencing eHAND expression.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Inhibits the Hedgehog signaling pathway, possibly affecting pathways that eHAND is a part of.